BioRestorative Therapies (BRTX) Revenue (2010 - 2026)
BioRestorative Therapies (BRTX) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM BioRestorative Therapies (BRTX) revenue is $350K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
BioRestorative Therapies (BRTX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -10.26% |
| 3 Years TTM | +39.12% |
| 5 Years TTM | +34.34% |
| 10 Years TTM | -2.70% |
Annual Revenue change of BioRestorative Therapies (BRTX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $20K | -94.44% |
| 2025 | $360K | -10.00% |
| 2024 | $400K | +166.67% |
| 2023 | $150K | +25.00% |
| 2022 | $120K | +140.00% |
| 2021 | $50K | -37.50% |
| 2020 | $80K | -38.46% |
| 2019 | $130K | +18.18% |
| 2018 | $110K | +37.50% |
| 2017 | $80K | +100.00% |
| 2016 | $40K | -93.65% |
| 2015 | $630K | +50.00% |
| 2014 | $420K | N/A |
| 2013 | $0 | -100.00% |
| 2012 | $20K | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | N/A |
| 2009 | $0 | N/A |
Comparison BioRestorative Therapies (BRTX) five years revenue CAGR with competitors
BioRestorative Therapies (BRTX) five years revenue CAGR is 38.99%.